News Search Results
Dec 11, 2025, 07:00 ET NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China
2025 /PRNewswire/ -- NewcelX Ltd. (Nasdaq: NCEL), a next-generation biotechnology company developing advanced cell-therapy and neuroscience-driven therapeutics, today announced the publication of a major international patent application
More news about: NewcelX Ltd.
Dec 11, 2025, 06:45 ET Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Dec 11, 2025, 03:03 ET India's Future Innovators to Converge at BML Munjal University for Heroes of Tomorrow Finale
cities including Hyderabad, Ludhiana, Dehradun and Delhi attracted strong participation, with students presenting business ideas in clean energy, biotechnology, healthcare technology, biodegradable materials and smart consumer solutions.The Hyderabad round, hosted at Canary The School, brought together
More news about: BML Munjal University
Dec 11, 2025, 01:00 ET OTR Therapeutics and Zealand Pharma enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases
Dec. 11, 2025 /PRNewswire/ -- OTR Therapeutics, a biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies for unmet medical needs, and Zealand Pharma A/S (Nasdaq: ZEAL), a biotechnology company transforming the future of metabolic health, today
More news about: OTR Therapeutics
Dec 10, 2025, 12:34 ET Locus FS Secures $40 Million in Strategic Investment to Accelerate Biomanufacturing & Bio-Based Additive Growth
Locus Fermentation Solutions (Locus FS), a U.S.-based biotechnology company producing performance-enhancing bio-based additives, today announced the close of an oversubscribed $20 million investment in a convertible
More news about: Locus Fermentation Solutions
Dec 10, 2025, 09:00 ET Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Chairman and CEO, Dr. Amit Kumar, will participate in the upcoming
More news about: Anixa Biosciences, Inc.
Dec 10, 2025, 09:00 ET Siolta Therapeutics Announces Upcoming Late Breaking Oral Presentation of Results from the Phase 2 ADORED trial at 2026 AAAAI meeting
SAN CARLOS, Calif., Dec. 10, 2025 /PRNewswire/ -- Siolta Therapeutics, a biotechnology company developing first-in-class live biotherapeutic products (LBPs), today announced that its abstract describing the one year results from the
More news about: Siolta Therapeutics
Dec 10, 2025, 09:00 ET Transformative Biotech Appoints Industry Veteran Kevin Kraus as CEO
board as we move our company forward and drive commercialization." About Transformative BiotechTransformative Biotech is a biotechnology company focused on deploying rapid, highly accurate, and robust, direct-to-PCR technologies with the power to transform molecular testing for infectious
More news about: Transformative Biotech, LLC
Dec 10, 2025, 08:52 ET Dose-Intensive CK0804 Regimen Reduces Spleen Volume and Transfusion Needs in JAK Inhibitor-Resistant/ Suboptimal Myelofibrosis with Thrombocytopenia
intravenously through a peripheral line in an outpatient setting.About Cellenkos, Inc.Cellenkos, Inc. is a clinical‑stage biotechnology company developing allogeneic, off‑the‑shelf T regulatory (Treg) cell therapies for autoimmune and inflammatory diseases. Tregs are key immune cells
More news about: Cellenkos, Inc.
Dec 10, 2025, 08:37 ET Aramore Wins "Best Breakthrough Wellness Startup" in the 2025 Glossy Awards
www.aramore.com and select retail partners nationwide.About AramoreFounded at the intersection of biotechnology and beauty, Aramore is a pioneering skincare brand focused on longevity through cellular health. Backed by scientific research from MIT and Harvard,
More news about: ARAMORE Skincare
Dec 10, 2025, 08:00 ET Diakonos Oncology Awarded Multi-Million-Dollar Research Grant by the Cancer Prevention and Research Institute of Texas to Advance DOC1021 in Refractory Melanoma
Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced that the Company was selected
More news about: Diakonos Oncology
Dec 10, 2025, 08:00 ET Expression Therapeutics Appoints Industry Veteran Dr. David Townson as Chief Executive Officer
access.About Expression Therapeutics Expression Therapeutics, Inc., based in Atlanta, Georgia, is a clinical-stage biotechnology company pioneering a curative gene therapy for hemophilia A and best-in-class cell therapies for neuroendocrine tumors (NETs) and neuroblastoma.
More news about: Expression Therapeutics, Inc.
Dec 10, 2025, 07:45 ET Publication in Nature's Scientific Reports Reinforces Spiderwort Biotechnologies' Cellulose-Based Platform with New Findings on Neural Repair and Motor Recovery
interdisciplinary academic research combining basic and applied research can accelerate discovery and translate scientific research into meaningful biotechnology innovations and commercial applications.""Spinal cord injury remains one of the most challenging conditions in neurosurgery and
More news about: Spiderwort Biotechnologies Inc.
Dec 10, 2025, 04:15 ET Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (ASC40), a First-in-Class FASN Inhibitor for Acne Treatment
(Nasdaq: SGMT) for exclusive rights in Greater China.About Ascletis Pharma Inc.Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases.
More news about: Ascletis Pharma Inc.
Dec 09, 2025, 20:30 ET D3 Bio Secures $108 Million in Series B Financing to Advance Global Clinical Programs
SHANGHAI, Dec. 9, 2025 /PRNewswire/ -- D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completion of a $108 million Series B financing
More news about: D3 Bio, Inc.
Dec 09, 2025, 16:07 ET BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair
Mr. Pagano is currently Chief Financial Officer and Executive Vice President of Genmab, a leading international biotechnology company, a position he has held since March 2020. He joined Genmab in December 2007, establishing a strong track record of driving financial performance
More news about: BillionToOne
Dec 09, 2025, 16:01 ET AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Dec 09, 2025, 15:30 ET Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama
Greenbrier South, Huntsville, Alabama site was selected from more than 300 applications, partly based on its proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus that supports workforce training and research. In addition to its workforce potential, the region offers ready
More news about: Eli Lilly and Company
Dec 09, 2025, 10:20 ET Immunostimulant Market to Reach $288.82 billion, Globally, by 2034 at 9.9% CAGR: Allied Market Research
infectious diseases, increasing prevalence of cancer and immune-related disorders, expanding vaccination initiatives, and continuous advancements in biotechnology, the immunostimulant market is gaining strong traction globally across prophylactic and therapeutic segments.Request Sample of the Report
More news about: Allied Market Research
Dec 09, 2025, 10:15 ET High-end Refractometer Market worth $0.38 billion by 2032 - Exclusive Report by MarketsandMarkets™
the high-end refractometer market include increasing demand for precise, real-time concentration and purity measurement across pharmaceuticals, biotechnology, food and beverage processing, and semiconductor manufacturing. The adoption of advanced optical technologies-such as multi-wavelength measurement,
More news about: MarketsandMarkets
Dec 09, 2025, 08:38 ET Sen-Jam Pharmaceutical Appoints Global Life Sciences Leader Rute Fernandes as Executive Advisor to Accelerate Commercialization Pathways
Sen-Jam Pharmaceutical is a clinical-stage biotechnology company reimagining how inflammation and addiction are treated through innovative, affordable, and rapidly deployable combination therapeutics.
More news about: Sen-Jam Pharmaceutical
Dec 09, 2025, 08:30 ET Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival
Dec. 9, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing cell-based therapies for diabetes and age-related disorders, today announced a newly published study from the Mayo
More news about: Avant Technologies Inc.
Dec 09, 2025, 08:28 ET Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Dec 09, 2025, 08:00 ET Vincere Cancer Center Begins Recruitment for Clinical Studies of Pioneering Breast Cancer Screen for Women at High Risk
detectionCALGARY, AB, Dec. 9, 2025 /PRNewswire/ - Syantra, Inc., a biotechnology company revolutionizing cancer detection, is announcing Scottsdale, Arizona based Vincere Cancer Center has launched recruitment for clinical testing
More news about: Syantra Inc.
Dec 09, 2025, 08:00 ET Curis Provides Updated Data from its Frontline AML Triplet Study
LEXINGTON, Mass., Dec. 9, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, yesterday provided updated
More news about: Curis, Inc.